Integrated Pest Management Lead

TerrAscend to participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference. MWN-AI** Summary. TerrAscend Corp. ("TerrAscend"), a prominent player in the North American cannabis industry, has announced its participation in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference, scheduled for September 9, 2026, in New York City. The company's executive team, including Executive Chairman Jason Wild and Chief Executive Officer Ziad Ghanem, will conduct one-on-one meetings throughout the event, signaling their commitment to engaging with institutional investors. Founded as a TSX-listed cannabis company, TerrAscend operates extensively across key markets in North America, including Pennsylvania, New Jersey, Maryland, Ohio, and California. The firm is recognized for its expansive retail operations through dispensaries such as The Apothecarium, as well as its robust cultivation, processing, and manufacturing capabilities. With a focus on quality, TerrAscend employs advanced cultivation and manufacturing practices to deliver a diverse and high-quality product selection, catering effectively to both medical and adult-use cannabis markets. TerrAscend's business model includes ownership and licensing of various synergistic brands such as Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One, and Valhalla, further solidifying its position within the industry. By participating in the institutional investor conference, TerrAscend aims to enhance its visibility among potential investors and showcase its strategic growth initiatives and product offerings. As the cannabis sector continues to evolve, TerrAscend's proactive approach to investor engagement demonstrates its strength in navigating the complexities of the market while aiming to maximize shareholder value. For more information about TerrAscend Corp and its offerings, interested parties can visit the company's official website or reach out to its investor relations team. MWN-AI** Analysis. TerrAscend Corp. (TSX: TSND, OTCQX: TSNDF) is poised to capture market interest, particularly with its upcoming participation in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference. This event on September 9 presents a strategic opportunity for TerrAscend's executive management, including Executive Chairman Jason Wild and CEO Ziad Ghanem, to engage with investors and showcase the company's growth potential. TerrAscend has established itself as a key player in the North American cannabis sector, with a diversified operational footprint spanning multiple lucrative markets, including Pennsylvania, New Jersey, Maryland, Ohio, and California. Its robust business model encompasses cultivation, processing, and retail, underpinned by a commitment to high-quality cannabis production for both medical and adult-use segments. With established brands like The Apothecarium and partnerships with companies like Cookies and Wana, TerrAscend stands out for its diverse product offering and brand synergy. The current state of the cannabis market, characterized by evolving legislation and increasing public acceptance, bodes well for companies like TerrAscend. This strategic positioning, coupled with the company's operational efficiencies and market penetration, could lead to favorable revenue trajectory in the near term. Investors should view TerrAscend's engagement at the conference as a pivotal moment for potential insights into the company's growth strategies and financial outlook. Interest in the cannabis sector remains high, and with management actively communicating their vision, this could translate into increased investor confidence and share price appreciation. In summary, for investors considering exposure to the cannabis industry, TerrAscend represents a compelling proposition, especially in light of its strong market presence and proactive investor engagement. Keeping an eye on developments from the upcoming conference could provide valuable insights for making informed investment decisions. **MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release. September 04, 2026 12:30:00 pm TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) - TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference held in New York City, on September 9, 2026. Jason Wild, Executive Chairman and Ziad Ghanem, Chief Executive Officer, will host one-on-one meetings throughout the conference. About TerrAscend Corp. TerrAscend Corp. is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One and Valhalla. For more information visit www.terrascend.com. Investor Relations Contact: KCSA Strategic Communications Valter Pinto, Managing Director [email protected] 212-896-1254 FAQ**. How does TerrAscend Corp TSNDF plan to leverage its presence at the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference to enhance investor relations and stakeholder engagement? TerrAscend Corp TSNDF aims to leverage its presence at the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference by showcasing its strategic initiatives and innovations to enhance transparency and foster closer relationships with investors and stakeholders. What specific goals does TerrAscend Corp TSNDF aim to achieve during the one-on-one meetings hosted by Jason Wild and Ziad Ghanem at the upcoming investor conference? TerrAscend Corp aims to communicate its growth strategy, showcase recent operational developments, and discuss financial performance and future projections during the one-on-one meetings hosted by Jason Wild and Ziad Ghanem at the upcoming investor conference. Can you provide insight into how TerrAscend Corp TSNDF's recent operational developments in Pennsylvania, New Jersey, and California are expected to impact its growth strategy moving forward? TerrAscend Corp's recent operational developments in Pennsylvania, New Jersey, and California are anticipated to bolster its growth strategy by expanding market reach, enhancing product offerings, and increasing revenue streams in key cannabis markets, driving overall profitability. What strategies is TerrAscend Corp TSNDF implementing to maintain its competitive edge in the evolving North American cannabis market, particularly with its diverse portfolio of brands? TerrAscend Corp is focusing on innovation through product diversification, expanding its distribution channels, enhancing brand recognition, and investing in sustainability to maintain its competitive edge in the evolving North American cannabis market. **MWN-AI FAQ is based on asking OpenAI questions about TerrAscend Corp (OTC: TSNDF).

TerrAscend to participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference. September 04, 2026 12:30 ET | Source: TerrAscend TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) - TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference held in New York City, on September 9, 2026. Jason Wild, Executive Chairman and Ziad Ghanem, Chief Executive Officer, will host one-on-one meetings throughout the conference. About TerrAscend Corp. TerrAscend Corp. is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One and Valhalla. For more information visit www.terrascend.com. Investor Relations Contact: KCSA Strategic Communications Valter Pinto, Managing Director [email protected] 212-896-1254

IRS pushes back on cannabis tax refunds as rescheduling reshapes 280E fight. MSOs are still hoping their tax gambit pays off. Reading Time: 3 mins read The Internal Revenue Service (IRS) is pushing back against multi-state operators, just as they have grown more bold when it comes to writing off cannabis-related business expenses in the wake of last spring's rescheduling of medical cannabis. A little more than two years ago, a few multi-state operators grabbed headlines with their claims that they figured out legal loopholes around article 280E of the U.S. tax code, which forbids companies from writing off expenses when the business is involved with a Schedule I or II drug. These loopholes would allow companies to recoup hundreds of thousands, if not millions of dollars in lost revenue from the IRS. Since then, the IRS has started filing cases in attempts to claw back erroneous cannabis-related tax returns, which was further complicated when acting Attorney General Todd Blanche officially announced medical cannabis would be moved to Schedule III, making it exempt from 280E. "The Attorney General's announcement made clear that state licensed medical cannabis sales are no longer subject to 280E taxes," said George Archos during Verano's (VERNOF) April 30 quarterly earnings call. "With almost 60% of our retail revenue derived from medical cannabis sales in the first quarter, we are in a position to immediately benefit from the medical rescheduling ruling from a tax perspective which we are actively evaluating as more information and guidance from the Treasury Department and IRS becomes available." Verano was just one of several companies that seem to be banking on tax savings in the wake of the rescheduling announcement. A rough accounting of potential tax savings if 280E did not apply to the top multi-state operators (MSO), would reach a reported $1.6 billion. Curaleaf (CURLF) has about $96.5 million in uncertain tax liabilities related to the enforcement of 280E, according to the company's interim financial report from May 5, 2026. "The Company has adopted a tax position, supported by legal interpretations, asserting that the restrictions of Section 280E do not apply to its cannabis operations," said the 59-page filing. "While the Company believes the Section 280E Position is supported by sound legal interpretations, the cannabis industry operates in a complex and evolving regulatory environment." TerrAscend (TSNDF) and Ascend Wellness (AAWH) both filed quarterly earnings reports for the first quarter of 2024 that included announcements the companies submitted revised tax returns for prior years in order to claim business expenses. At the time, neither company was explicitly about their respective legal strategies supporting their claims. TerrAscend expects up to $26 million in tax returns for their amended claims, while Ascend Wellness did not disclose how much they expect back. The previous month, Trulieve announced it received $112 Million in tax refunds after resubmitted claims. The IRS attempts to claw back cannabis tax returns Despite the increasingly bullish approach MSOs appear to have toward writing off business expenses, the federal government has begun challenging those attempts in court. The IRS sued TerrAscend on May 18, 2026, seeking repayment of tax returns that it claims were erroneously paid. Prior to that, the IRS filed what is likely the first lawsuit attempting to claw back cannabis tax returns that were prohibited under 280E, when the government filed suit against New Mexico Top Organics at the end of 2024. Recently in the New Mexico Top Organics case, the IRS argued on March 6, 2026, that federal courts up to that point have been consistent in how the law regards cannabis, particular in terms of the U.S. tax case. "Despite many taxpayer challenges, federal courts have consistently held that section 280E is constitutionally valid and have created a robust legal authority supporting its validity and applicability to sellers of marijuana," said the IRS in a 45-page seriatim answering brief before the U.S Tax Court. About six weeks later, on April 22, the federal government moved medical cannabis to Schedule III, meaning 280E no longer applied. The proposed rule was published in the Federal Register on April 28. New Mexico Top Organics answered the IRS's argument on May 18, with a 27-page response. "The rescheduling order reflects an understanding that medical marijuana has fit within the meaning of Schedule III (rather than Schedule I) for a long time," said the response. The case remains pending, just as the federal rescheduling process continues. Hearings pertaining to the scheduling of adult-use cannabis are expected to last as late as July 15.